Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-19FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from Zydus Lifesciences Limited to market the generic co…
-
FDA label_change · 2024-01-25FDA Approved: ACETAZOLAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for acetazolamide by Hikma Pharmaceuticals USA Inc., resulting in labeling and/or manufacturing chan…
-
FDA approval · 2024-01-08FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for Triamterene and Hydrochlorothiazide submitted by Chartwell RX, LLC.
-
FDA approval · 2023-10-23FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for hydrochlorothiazide from Oxford Pharmaceuticals, LLC. This action pertains to regulatory approva…
-
FDA approval · 2023-10-10FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for spironolactone by Mylan Pharmaceuticals Inc., updating the approval for this generic diuretic. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-05FDA Approved: SPIRONOLACTONE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original ANDA for spironolactone from Amneal Pharmaceuticals NY LLC, enabling a generic version of the diuretic.
-
FDA approval · 2023-08-25FDA Approved: ACETAZOLAMIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for acetazolamide sodium filed by Mylan Institutional LLC, approving the salt form of acetazolamide …
-
FDA approval · 2023-08-24FDA Approved: SPIRONOLACTONE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for spironolactone from Padagis US LLC, indicating an updated regulatory action on this product (sup…
-
FDA approval · 2023-08-16FDA Approved: ACETAZOLAMIDE — Supplemental Application (TRUPHARMA, LLC)
FDA approved a supplemental application for acetazolamide from TRUPHARMA, LLC under ANDA 211372. This action updates the approval status of …
-
FDA approval · 2023-08-16FDA Approved: ACETAZOLAMIDE — Supplemental Application (Eywa Pharma Inc)
The FDA approved Eywa Pharma Inc's supplemental application for acetazolamide, enabling continued marketing of a generic acetazolamide produ…
-
FDA approval · 2023-08-09FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for acetazolamide, finalizing approval for changes to the approved generic produc…
-
FDA approval · 2023-07-24FDA Approved: BUMETANIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original ANDA for bumetanide, a loop diuretic used to treat edema and related conditions.
-
FDA approval · 2023-06-23FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for spironolactone by Oxford Pharmaceuticals, LLC. The approval allows continued marketing of the ge…
-
FDA approval · 2023-05-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical's spironolactone and hydrochlorothiazide combination product. The submission …
-
FDA approval · 2023-05-10FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2023-05-09FDA Approved: ACETAZOLAMIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved acetazolamide as an original ANDA from Marlex Pharmaceuticals, providing a generic version of the carbonic anhydrase inhibitor.…
-
FDA approval · 2023-04-20FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Mylan Pharmaceuticals Inc., potentially updating label…
-
FDA approval · 2023-03-16FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydrochlorothiazide submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals In…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: PVP-Guided Decongestive Therapy in HF [Phase 4]
Phase 4 clinical trial update on PVP-guided decongestive therapy for heart failure and edema shows ongoing status.
-
FDA approval · 2023-02-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the generic Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc., a combinatio…
-
FDA approval · 2023-01-23FDA Approved: ACETAZOLAMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Acetazolamide (generic) submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals In…
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Lornoxicam Versus Etodolac After Third Molar Surgery [Phase 4]
A Phase 4 clinical trial comparing lornoxicam to etodolac after third molar surgery has completed.
-
FDA approval · 2022-12-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for the combination product spironolactone and hydrochlorothiazide, manufactured by Prasco Laborator…
-
FDA approval · 2022-12-16FDA Approved: FUROSEMIDE — Original Application (Lifestar Pharma LLC)
FDA approved Lifestar Pharma LLC's original application for furosemide, authorizing the generic version of the diuretic for its labeled indi…
-
FDA approval · 2022-10-25FDA Approved: METOLAZONE — Original Application (Aarkish Pharmaceuticals NJ Inc.)
FDA approved the original application for metolazone from Aarkish Pharmaceuticals NJ Inc., granting clearance to manufacture and market a ge…